Erika Burbano

Erika Burbano practices at Andrew Marlowe, MD, PA in Sarasota, Florida.

Erika Burbano's NPI, 1184257255, was assigned on February 18, 2020. Erika Burbano holds Florida license PA9112646.

Erika Burbano's primary practice is Andrew Marlowe, MD, PA, at 5432 Bee Ridge Rd, Sarasota, FL 34233 in Sarasota County. The practice phone is (941) 379-3277.

Erika Burbano's primary practice is Andrew Marlowe, MD, PA in Sarasota, Florida. Erika Burbano is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Marlowe MD ENT. Dmand AI also links Erika Burbano to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Erika Burbano practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Erika Burbano's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Erika Burbano is licensed in Florida.

Dmand AI lists anxiety, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, itchy rashes and lower back pain among the conditions Erika Burbano treats.

CMS data shows 1,841 Medicare services from Erika Burbano across 13 procedure codes in 2024, for 748 Medicare patients. Medicare paid $92,748 for them. Every service was in an office.

CMS counts 748 Medicare patients who saw Erika Burbano in 2024. The largest group is 75 to 84, with 323 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 1% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Erika Burbano's median patient age at 71, with 62% women.

In 2024, Erika Burbano wrote 1,050 Medicare Part D claims for 381 patients. 94% of them were for generic drugs. CMS names the drug for 939 of them, across 26 drugs with 11 or more claims each, at $54,051 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 67 out of 100 for Erika Burbano for performance year 2024, reported individually. Erika Burbano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 83 general payments to Erika Burbano from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $572.